Dawei Lin
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Protein Structure and Dynamics
- Ubiquitin and proteasome pathways
- Microbial Metabolic Engineering and Bioproduction
Papers in
-
- Signaling Pathways in Disease 2
-
- Cardiac Valve Diseases and Treatments 7
- Cardiovascular Function and Risk Factors 4
- Cardiac Arrhythmias and Treatments 2
- Co-authors
- Peter Kaiser (8 shared papers)Rommie E. Amaro (2 shared papers)Hartmut Luecke (2 shared papers)Richard H. Lathrop (2 shared papers)G. Wesley Hatfield (2 shared papers)Linda Hall (2 shared papers)Özlem Demir (2 shared papers)Chiung-Kuang Chen (2 shared papers)
- Journals
- Nature Communications (2 papers)BioScience Trends (2 papers)Journal of Biological Chemistry (2 papers)BMC Cardiovascular Disorders (2 papers)BMJ Open (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Dawei Lin
25 papers receiving 414 citations
Peers
Comparison fields: 5 of 74
- Biotechnology 64
- Molecular Biology 296
- Oncology 116
- Cancer Research 52
- Biochemistry 23
Countries citing papers authored by Dawei Lin
This map shows the geographic impact of Dawei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Lin more than expected).
Fields of papers citing papers by Dawei Lin
This network shows the impact of papers produced by Dawei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Lin. The network helps show where Dawei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 180 | |
| 2 | 2013 | 43 | |
| 3 | 2021 | 32 | |
| 4 | 2008 | 31 | |
| 5 | 2012 | 29 | |
| 6 | 2021 | 14 | |
| 7 | 2019 | 13 | |
| 8 | 2021 | 11 | |
| 9 | 2023 | 7 | |
| 10 | 2021 | 7 | |
| 11 | 2019 | 6 | |
| 12 | 2023 | 6 | |
| 13 | Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53 - eScholarship | 2013 | 6 |
| 14 | 2021 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2008 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2025 | 2 |
About Dawei Lin
Dawei Lin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience and Oncology, having authored 33 papers that have together received 415 indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (7 papers), Pulmonary Hypertension Research and Treatments (5 papers), Cardiovascular Function and Risk Factors (4 papers), Cancer Research and Treatments (3 papers), Infective Endocarditis Diagnosis and Management (3 papers), Aortic Disease and Treatment Approaches (3 papers), Signaling Pathways in Disease (2 papers) and Cardiac Arrhythmias and Treatments (2 papers). The work is most often cited by research in Biotechnology (64 citations), Molecular Biology (296 citations), Oncology (116 citations), Cancer Research (52 citations) and Biochemistry (23 citations). Dawei Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Peter Kaiser, Rommie E. Amaro, Hartmut Luecke, Richard H. Lathrop, G. Wesley Hatfield, Linda Hall, Özlem Demir, Chiung-Kuang Chen, Roberta Baronio and A. Richard Chamberlin. Their work appears in journals such as Nature Communications, BioScience Trends, Journal of Biological Chemistry, BMC Cardiovascular Disorders and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.